← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Protez Pharmaceuticals, Inc.
Malvern, PA
$4,467,383
Total funding
5
Grants
Funding mix
By agency
NIH$4,467,383 · 5
By mechanism
U01$3,185,404 · 1
R44$871,000 · 1
R43$410,979 · 3
Investigators at Protez Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
PTE-based drug for antibiotic-resistant anthrax$1,280,271
U01 · FY2004 · AI
PTE-based drug for antibiotic-resistant anthrax$1,156,790
U01 · FY2005 · AI
PTE-based drug for antibiotic-resistant anthrax$675,544
U01 · FY2003 · AI
Potentiators of fluconazole activity in Candida$444,000
R44 · FY2001 · AI
Potentiators of fluconazole activity in Candida$381,800
R44 · FY2002 · AI
POTENTIATORS OF BACTERIOSTATIC ANTIBIOTICS IN GRAM +$185,000
R43 · FY2000 · AI
EFFLUX INHIBITORS FOR MYCOBACTERIUM THERAPIES$99,700
R43 · FY2001 · AI
Bactericidal agents for slow-growing bacteria$78,278
R43 · FY2003 · AI
PTE-based drug for antibiotic-resistant anthrax$72,799
U01 · FY2003 · AI
Bactericidal agents for slow-growing bacteria$48,001
R43 · FY2003 · AI
Potentiators of fluconazole activity in Candida$45,200
R44 · FY2002 · AI